Gagandeep retweeted
🧬 Ahead of #ACR26, I’m delighted to share the launch of the Autoimmune Cell Therapies Forum (@TheACTForum) & honoured to be appointed its Chair
🚀 Our mission is simple: to make the rapidly evolving world of cell therapies more accessible
🔗 Register: celltherapy-forum.com
Meet the ACT Forum Steering Committee! 👋
Bringing together leading experts in autoimmune cell therapies to connect HCPs with emerging evidence, clinical trials and the latest advances in this rapidly evolving field.
🔗 ow.ly/7oUR5103f2B
🌍 This #WorldArthritisDay, we asked the #eularEMEUNET community: What is YOUR dream for the future of people living with RMDs? 💭
💚 Every voice matters. Every dream counts.
A huge thank you to everyone who shared their dreams with us! 🙌
#WAD2026 #AchieveYourDreams #RMDreams
💬 What is YOUR dream for the future of people living with rheumatic and musculoskeletal diseases (RMDs)?
Share it in the comments 👇
On 12 Oct, #WorldArthritisDay, we’ll share your responses across our social media platforms.
#WAD2026 #AchieveYourDreams #RMDreams
🚀 Call for applications 🚀
Apply now as EMEUNET representative for one of the 10 EULAR Task Forces covering various RMDs and topics.
📣 Apply now! pulse.ly/4qzrkhwgmk
⏰ Deadline: 18 October
#EULAR #eularEMEUNET #Rheumatology #TaskForce #Research
✨ What is EMEUNET all about?
Who are we and what is our mission? 🌍
From education and research to communication, networking and much more — our subcommittees are at the heart of everything we do. 💜
🎬 Our new EMEUNET video is coming soon!
#eularEMEUNET #EULAR #Rheumatology
📢 Ready to strengthen your peer review skills? ✍️📚
Applications are now open for the EMEUNET Peer Review Mentoring Programme.
👉 Apply here: pulse.ly/puyaui05kw
📅 Deadline: 21 June 2026
Presented at #EULAR2026:
Among patients with relapsed polymyalgia rheumatica, treatment with secukinumab plus a 24-week glucocorticoid taper resulted in a higher percentage of patients with remission than a glucocorticoid taper alone. Full phase 3 REPLENISH trial results: nej.md/3PvmmMO
Editorial: Emerging Era for Polymyalgia Rheumatica and GCA — Interleukin-17A Targeting nej.md/4dB5b5I
Original Article in @NEJMEvidence: Secukinumab for Giant Cell Arteritis (phase 3 GCAptAIN trial) eviden.cc/49CLAj9
@eular_org

ALT Chart from an article published in the New England Journal of Medicine showing results from a phase 3 trial of secukinumab in polymyalgia rheumatica. Two bar graphs depict sustained remission and complete sustained remission at week 52, comparing secukinumab, 300 mg (dark blue bars); secukinumab, 150 mg (light blue bars); and placebo (grey bars). Statistical significance is noted with P<0.001 for each comparison.
Just saw! Daraxonrasib getting a standing ovation at #ASCO2026 for significant survival benefit in pancreatic cancer. Amazing news for pancreatic cancer patients!
KRAS — 'undruggable' for 40 years — just fell.
It got me thinking — what in rheumatology could deserve that moment.
Probably it would be CD19 CAR-T in lupus/myositis. Can autoimmunity be cured? Patients off ALL immunosuppression. Drug-free remission. Early trials. Extraordinary results.
And what about other specialties? These are the few that come to mind…
🩸 Haematology: Teclistamab in myeloma. 71% reduction in disease progression. Chemotherapy-free. Myeloma could be becoming a chronic disease.
❤️ Cardiology: Pelacarsen targeting Lp(a). The cardiovascular risk factor statins can’t touch. Affects 20% of us. Phase III outcomes data expected. Worth an ovation?
🟤 Gastroenterology: Resmetirom in MASH. Fatty liver disease — silent, massive, untreatable. Until now.
💊 Infectious Disease: Lenacapavir. Twice-yearly injection. 100% efficacy in HIV prevention. Massive.
Science at its finest — targeting the root, changing the trajectory.
What would earn a standing ovation in YOUR specialty? 👇
#MedTwitter #Rheum #ASCO2026 #Innovation #Medicine
1
32
This will be so good for healthcare whenever it happens. we can have experts everywhere and not just in selected places or countries! #equailityinhealthcare
Elon Musk on how Optimus will provide access to the best medical care for anyone in the world:
“Imagine a world where everyone has access to the best surgeons, literally everyone. And Optimus will have the level of precision that is frankly superhuman and will be able to do medical procedures, very sophisticated medical procedures, any medical procedure, perhaps things that humans can't even do because they're too difficult, and that will be available to anyone. People often talk about eliminating poverty and providing great medical care, but they never actually have a solution.
Money doesn't solve it, because there are only so many, there's a very limited number of great doctors and surgeons, they don't grow on trees. But now they all get built in factories.”
25
An interesting overview of diet and disease susceptibility!! Worth reading nature.com/articles/s41579-0…
54
Gagandeep retweeted
The #EMEUNET quiz was one of our favorite sessions at #EULAR2024!
There was some tough competition this year with questions on a variety of rheumatology topics.
We proudly congratulate the winners:
1st: Manuel Vincent Wegner & Gagandeep Sukhija
2nd: Franz Thiele & Chantal Meier
Gagandeep retweeted
Tough competition at the #EMEUNET quiz!
#EULAR2024
#Eular2024 wrapped up-incredible learning experience and top notch networking opportunities.
Thank you to an amazing #kingsrheum team especially @chriswincup @Artimahto_rheum.
Wonderful to have met @docrota and Dr Khanna.
Thank you @EMEUNET for the quiz and mentor mentee meet
1
15
498
Thank you @chriswincup for making this a wonderful #eular2024.
The @EMEUNET quiz was the extra icing on the cake to an already incredible 4 days!!
The whole #kingsrheum team was amazing!!!
#EULAR2024
I’m also incredibly proud of my colleagues & our trainees from King’s for delivering some fantastic sessions
@gagan43 presented brilliantly on the #SLE poster tour
Eman Elfar & Melissa Ong did a great job presenting their #SLE posters for the first time at EULAR too
6
312
Day 2 @eular2024- Amazing Mentor Mentee meeting @EMEUNET
Thank you @chriswincup and Prof Matucci for sharing their stories and advice.
-Having enthusiasm, determination and being independent - the key takeaways!!
#EULAR24
1
138






























